
Aurobindo Pharma Ltd
NSE:AUROPHARMA

Intrinsic Value
The intrinsic value of one
AUROPHARMA
stock under the Base Case scenario is
1 140.77
INR.
Compared to the current market price of 1 105.35 INR,
Aurobindo Pharma Ltd
is
Undervalued by 3%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Aurobindo Pharma Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Aurobindo Pharma Ltd
Balance Sheet Decomposition
Aurobindo Pharma Ltd
Current Assets | 262.3B |
Cash & Short-Term Investments | 75.2B |
Receivables | 54B |
Other Current Assets | 133B |
Non-Current Assets | 218.7B |
Long-Term Investments | 8.1B |
PP&E | 149.2B |
Intangibles | 40.1B |
Other Non-Current Assets | 21.3B |
Free Cash Flow Analysis
Aurobindo Pharma Ltd
INR | |
Free Cash Flow | INR |
Earnings Waterfall
Aurobindo Pharma Ltd
Revenue
|
309.2B
INR
|
Cost of Revenue
|
-126.6B
INR
|
Gross Profit
|
182.6B
INR
|
Operating Expenses
|
-133.2B
INR
|
Operating Income
|
49.4B
INR
|
Other Expenses
|
-14.5B
INR
|
Net Income
|
34.9B
INR
|
AUROPHARMA Profitability Score
Profitability Due Diligence
Aurobindo Pharma Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Score
Aurobindo Pharma Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
AUROPHARMA Solvency Score
Solvency Due Diligence
Aurobindo Pharma Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Score
Aurobindo Pharma Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AUROPHARMA Price Targets Summary
Aurobindo Pharma Ltd
According to Wall Street analysts, the average 1-year price target for
AUROPHARMA
is 1 505.91 INR
with a low forecast of 1 151.4 INR and a high forecast of 2 026.5 INR.
Dividends
Current shareholder yield for AUROPHARMA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
AUROPHARMA
stock under the Base Case scenario is
1 140.77
INR.
Compared to the current market price of 1 105.35 INR,
Aurobindo Pharma Ltd
is
Undervalued by 3%.